BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Stopped: The Six-Year Cost of Trials That Never Reached the Finish Line

One infusion, no programme A gene therapy is a one-way door. The vector goes in once, it cannot be taken out, and with current adeno-associated virus tech...

July 28, 2026 | Analysis

Biointron Launches RushData to Accelerate AI-Driven Antibody Discovery with High-Throughput Experimental Validation

1-day CHO expression for data generation in days, not weeks, for standardized, structured datasets ready for AI/ML-driven design Custom workflows for ...

July 28, 2026 | News

Harbour BioMed Forecasts Record H1 2026 Profit as Strategic Partnerships Drive Growth

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutic...

July 27, 2026 | Company results

Nova Biomedical Expands Cell Line Development Portfolio with NanoCellect Technology Acquisition

Nova Biomedical announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expands Nova Bio...

July 27, 2026 | News

Nona Biosciences Partners with MedUni Vienna to Advance Fully Human Antibody Research

Partnership grants Ignaz Semmelweis Institute access to Nona's H2L2 Harbour Mice® transgenic mouse technology platform for translational antibody ...

July 24, 2026 | News

Discount or Validation? Western Pharma’s Appetite for Chinese Assets

There is a number that has stopped being a niche statistic for Asia-watchers and started reshaping where the global drug industry shops. The average upfron...

July 24, 2026 | Analysis

Lonza and Engitix Partner to Advance Next-Generation ECM-Targeted ADCs

Lonza grants Engitix target-specific license for GlycoConnect®, HydraSpace® and SYNtecan E™ linker-payload technologies for ADC de...

July 22, 2026 | News

Lundbeck Completes Patient Randomisation in Phase III Bexicaserin Trial for Rare Epilepsies

DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with DEEs, a diverse ...

July 22, 2026 | News

Vector Partners with Caresyntax to Build Real-World Evidence Programme for Opioid-Sparing Surgical Platform

Caresyntax will design and operate a multi-phase real-world evidence program for Vector, culminating in a prospective comparative reg...

July 21, 2026 | News

Samsung Biologics Launches CHF 1.46B All-Cash Bid to Acquire PolyPeptide

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury share...

July 21, 2026 | News

Australia and Taiwan Build a Faster Clinical Bridge for Global Biotech Development

As biotechnology companies face mounting pressure to move promising science into human studies faster, the relationship between Australia and Taiwa...

July 20, 2026 | News

From Capacity to Capability: The New Race to Lead ASEAN Biomanufacturing

ASEAN is entering a new phase of biopharmaceutical manufacturing, where simply building more capacity will no longer guarantee competitiveness. As ...

July 17, 2026 | Expert Insight

Septa Pharmaceuticals Acquires CeeNU from Bristol Myers Squibb Canada

Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU...

July 17, 2026 | News

Metabolon Expands Microbiome Panel to Screen Over 800 Metabolites

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health,...

July 17, 2026 | News

Stay Connected